DEERFIELD, Ill.--(BUSINESS WIRE)--May 30, 2018--
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal
2018 third quarter earnings results at 7 a.m. Eastern time Thursday, 28
June 2018, followed by a one-hour conference call with Walgreens Boots
Alliance management beginning at 8:30 a.m. Eastern time.
The conference call will be simulcast through the Walgreens Boots
Alliance investor relations website at: http://investor.walgreensbootsalliance.com.
A replay of the conference call will be archived on the website for 12
months after the call.
The replay also will be available from 11:30 a.m. Eastern time, 28 June
2018 through 5 July 2018, by calling +1 855 859 2056 within the U.S. and
Canada, or +1 404 537 3406 internationally, using replay code 7668398.
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led,
health and wellbeing enterprise. The company's heritage of trusted
health care services through community pharmacy care and pharmaceutical
wholesaling dates back more than 100 years.
Walgreens Boots Alliance is the largest retail pharmacy, health and
daily living destination across the U.S. and Europe. Walgreens Boots
Alliance and the companies in which it has equity method investments
together have a presence in more than 25* countries and employ more than
385,000* people. The company is a global leader in pharmacy-led, health
and wellbeing retail and, together with the companies in which it has
equity method investments, has more than 13,200* stores in 11* countries
as well as one of the largest global pharmaceutical wholesale and
distribution networks, with more than 390* distribution centers
delivering to more than 230,000** pharmacies, doctors, health centers
and hospitals each year in more than 20* countries. In addition,
Walgreens Boots Alliance is one of the world’s largest purchasers of
prescription drugs and many other health and wellbeing products.
The company’s portfolio of retail and business brands includes
Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as
increasingly global health and beauty product brands, such as No7, Soap
& Glory, Liz Earle, Sleek MakeUP and Botanics.
More company information is available at www.walgreensbootsalliance.com.
* As of 31 August 2017, using publicly available information for
** For 12 months ending 31 August 2017, using publicly available
information for AmerisourceBergen
Cautionary Note Regarding Forward-Looking Statements:All
statements in this release and related conference call and webcast that
are not historical are forward-looking statements made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements are not guarantees of future
performance and involve risks, assumptions and uncertainties, including
those described in Item 1A (Risk Factors) of our Form 10-K for the
fiscal year ending 31 August 2017, and our Form 10-Q for the fiscal
quarter ending 30 November 2017, each of which is incorporated herein by
reference, and in other documents that we file or furnish with the
Securities and Exchange Commission. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially. These forward-looking
statements speak only as of the date they are made. Except to the extent
required by law, we do not undertake, and expressly disclaim, any duty
or obligation to update publicly any forward-looking statement after the
date of this release, whether as a result of new information, future
events, changes in assumptions or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180530005086/en/
Source: Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
Fiona Ortiz, +1 847 315 6402
International / Laura Vergani,
+44 (0)207 980 8585
Gradwell and Ashish Kohli, +1 847 315 2922